Of the 42 subjects with PD (including DBS PD), 34 subjects were also treated with other medications for PD in addition to levodopa, dopamine agonists (67% of patients) and monoamine oxidase B inhibitors (61% of patients) being clearly the most common classes of these medications. Here, MAOB is linked to Parkinson disease.